Work

Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-s1-03

Authors: VC Tjan-Heijnen, IE Van Hellemond, PG Peer, AC Swinkels, CH Smorenburg, M Van der Sangen, JR Kroep, H De Graaf, AH Honkoop, F Erdkamp, FW Van den Berkmortel, JJ Kitzen, M De Boer, WK De Roos, SC Linn, AL Imholz, C Seynaeve

Institutions: Leiden University Medical Center, Maastricht University Medical Centre, Zuyderland Medisch Centrum, Netherlands Comprehensive Cancer Organisation, Erasmus MC Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594470360

Cites:

Cited by: 30

Related to: 10